🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ambroxol is a simple cough medicine that is predicted to slow ALS disease p...
Status
Unknown
Location
Brain and Mind Centre
Start Date
2023-06-13
Trial ID
NCT05959850
Patients with mild and severe COVID 19 will be randomized 1:1 into two grou...
Status
Unknown
Location
Lomonosov Moscow State University Medical Research and Educational Center
Start Date
2020-05-16
Trial ID
NCT04424134
Treatments Being Tested
The objective of the current study is to investigate relative bioavailabili...
Status
Completed
Location
65.129.1 Boehringer Ingelheim Investigational Site
Start Date
2011-08
Trial ID
NCT01423721
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled c...
Status
Recruiting
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University
Start Date
2025-01-20
Trial ID
NCT06693362
Treatments Being Tested
This is a randomized controlled trial of the efficacy and safety evaluation...
Status
Completed
Location
Almazov National Medical Research Centre
Start Date
2020-05-14
Trial ID
NCT04405999
Treatments Being Tested
This study will investigate the security and efficacy of a daily low dose o...
Status
Unknown
Location
National Institute of Rehabilitation, Luis Guillermo Ibarra Ibarra
Start Date
2021-02-01
Trial ID
NCT04340349
Treatments Being Tested
Ambroxol is a mucolytic containing an active N-desmethyl metabolite of brom...
Status
Completed
Location
Hospital Canselor Tuanku Muhriz UKM (HCTM)
Start Date
2023-01-07
Trial ID
NCT05663905
Treatments Being Tested
The purpose of this study is to evaluate the drug-durg interaction between ...
Status
Completed
Location
Samsung medical center
Start Date
2012-02
Trial ID
NCT01573663
Treatments Being Tested
This study will evaluate the safety, tolerability and pharmacodynamics of a...
Status
Completed
Location
Leonard Wolfson Experimental Neurology Centre Clinical Research Facility LWENC CRF
Start Date
2016-12
Trial ID
NCT02941822
Treatments Being Tested
The aim of this trial is to investigate the efficacy and tolerance of Ambro...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2007-08-01
Trial ID
NCT00525044